Johnson & Johnson

JNJ
Delayed Nyse - 10/18 10:00:19 pm
127.7USD
-6.22%
Prev.136.1700
Open133.3100
High134.3875
Low127.7000
Volume8 612 673
Financials
Sales 2019 82 226 M
EBIT 2019 25 622 M
Net income 2019 19 665 M
Debt 2019 7 881 M
Yield 2019 2,94%
P/E ratio 2019 17,7x
P/E ratio 2020 16,6x
EV / Sales2019 4,19x
EV / Sales2020 3,93x
Capitalization 337 B
Company
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows:
- pharmaceutical products (49.9%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses,...
Sector :
Pharmaceuticals - NEC
Calendar :
2019-10-23 Presentation
Trading Rating :
Investor Rating :
Latest news
10/19JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 3rd Update
DJ
10/19J&J Recalls Baby Powder For Asbestos -- WSJ
DJ
10/18MARKET SNAPSHOT: Dow Ends Lower Pressured By Boeing, Johnson & Johnson, Despite Good Earnings
DJ
10/18JOHNSON & JOHNSON : J&J Recalls Baby Powder on Asbestos Concern -- 2nd Update
DJ
10/18JPMORGAN CHASE, FACEBOOK, COCA-COLA : Stocks That Defined the Week
DJ
10/18CARDINAL HEALTH : Opioid negotiations fail to produce deal just before trial
AQ
10/18Johnson & Johnson Down Over 5%, on Pace for Largest Percent Decrease Since December 2018 -- Data Talk
DJ
10/18J&J Recalls Baby Powder on Asbestos Concern -- Update
DJ
Technical analysis trends
Short TermMid-TermLong Term
TrendNeutralNeutralNeutral
Resistance136144147
Spread/Res.-6,2%-11%-13%
Spread/Supp.0,59%0,59%0,34%
Support127127127